NP

Noorsaba Parveen

Active Director Director DIN 11117596
DIN 11117596 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Noorsaba Parveen

Data last updated:

Noorsaba Parveen is a Director at Troncell Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11117596
Primary Designation Director
Industry Pharma
First Appointment 21 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 May 20252025Active

Directorship timeline

Open interactive timeline →
Troncell Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Noorsaba Parveen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Noorsaba Parveen

Noorsaba Parveen currently holds 1 directorship: Troncell Pharmaceuticals Private Limited (Director, since 21 May 2025).

Noorsaba Parveen was first appointed on 21 May 2025 as Director at Troncell Pharmaceuticals Private Limited.

The current boards of Noorsaba Parveen's companies include Alvia Sarwat (Troncell Pharmaceuticals Private Limited), Mohammad Shadab Karim (Troncell Pharmaceuticals Private Limited), Saba Perween (Troncell Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available